Current Neuropharmacology
N1-methylnicotinamide Mediates Multi-Target Cognitive Deficit Relief via AMPK-Lysosome Axis Regulation
Experiments in animalsInterventions
The paper
The Third Xiangya Hospital; Central South University
Current Neuropharmacology, 30 Sep 2026

